Medtronic Return on Tangible Equity 2010-2024 | MDT
Medtronic Return On Tangible Equity Historical Data | |||
---|---|---|---|
Date | TTM Net Income | Tangible Equity | Return on Tangible Equity |
2024-01-31 | $4.20B | $-2.85B | -110.61% |
2023-10-31 | $4.10B | $-3.23B | -93.47% |
2023-07-31 | $3.62B | $-4.50B | -78.97% |
2023-04-30 | $3.76B | $-4.60B | -87.97% |
2023-01-31 | $4.06B | $-5.21B | -102.48% |
2022-10-31 | $4.32B | $-4.02B | -112.54% |
2022-07-31 | $5.21B | $-3.26B | -120.22% |
2022-04-30 | $5.04B | $-3.38B | -95.95% |
2022-01-31 | $4.91B | $-4.71B | -76.39% |
2021-10-31 | $4.70B | $-5.98B | -61.75% |
2021-07-31 | $3.88B | $-6.95B | -45.93% |
2021-04-30 | $3.61B | $-8.10B | -40.29% |
2021-01-31 | $2.89B | $-9.45B | -32.37% |
2020-10-31 | $3.54B | $-9.31B | -41.77% |
2020-07-31 | $4.41B | $-8.94B | -52.56% |
2020-04-30 | $4.79B | $-8.03B | -55.60% |
2020-01-31 | $5.32B | $-7.59B | -57.88% |
2019-10-31 | $4.67B | $-9.01B | -46.65% |
2019-07-31 | $4.42B | $-9.82B | -43.40% |
2019-04-30 | $4.63B | $-10.31B | -45.39% |
2019-01-31 | $4.92B | $-10.90B | -48.05% |
2018-10-31 | $2.26B | $-9.71B | -21.70% |
2018-07-31 | $3.16B | $-9.90B | -30.05% |
2018-04-30 | $3.10B | $-10.44B | -28.47% |
2018-01-31 | $2.81B | $-11.63B | -25.08% |
2017-10-31 | $5.02B | $-10.12B | -39.29% |
2017-07-31 | $4.12B | $-11.42B | -27.85% |
2017-04-30 | $4.03B | $-11.59B | -24.96% |
2017-01-31 | $3.97B | $-17.94B | -22.91% |
2016-10-31 | $4.24B | $-18.15B | -24.87% |
2016-07-31 | $3.65B | $-16.85B | -21.84% |
2016-04-30 | $3.54B | $-16.34B | -21.61% |
2016-01-31 | $2.43B | $-16.88B | -15.08% |
2015-10-31 | $2.32B | $-16.74B | -22.71% |
2015-07-31 | $2.62B | $-15.55B | -58.03% |
2015-04-30 | $2.68B | $-15.40B | 291.47% |
2015-01-31 | $3.12B | $6.88B | 48.74% |
2014-10-31 | $2.91B | $5.98B | 46.28% |
2014-07-31 | $2.98B | $6.21B | 48.04% |
2014-04-30 | $3.07B | $6.56B | 50.68% |
2014-01-31 | $3.59B | $6.39B | 61.57% |
2013-10-31 | $3.81B | $5.67B | 70.45% |
2013-07-31 | $3.56B | $5.57B | 68.71% |
2013-04-30 | $3.47B | $5.67B | 69.69% |
2013-01-31 | $3.49B | $4.74B | 74.36% |
2012-10-31 | $3.44B | $4.73B | 74.00% |
2012-07-31 | $3.66B | $4.76B | 82.45% |
2012-04-30 | $3.62B | $4.53B | 84.62% |
2012-01-31 | $3.40B | $4.54B | 83.57% |
2011-10-31 | $3.39B | $3.92B | 91.56% |
2011-07-31 | $3.09B | $4.10B | 85.00% |
2011-04-30 | $3.10B | $3.72B | 87.71% |
2011-01-31 | $3.28B | $3.07B | 93.07% |
2010-10-31 | $3.18B | $3.63B | 85.98% |
2010-07-31 | $3.48B | $3.70B | 98.22% |
2010-04-30 | $3.10B | $3.68B | 95.34% |
2010-01-31 | $2.25B | $3.80B | 75.92% |
2009-10-31 | $2.11B | $3.01B | 75.69% |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Products Manufacturing | $105.881B | $31.227B |
Medtronic, Inc. acquired Ireland-based Covidien plc. The acquisition resulted in the formation of a new holding company incorporated in Ireland - Medtronic plc. The company currently generates revenues from four major segments - namely Cardiovascular Portfolio, Medical Surgical Portfolio, Neuroscience Portfolio and Diabetes. The Cardiovascular Portfolio, formerly reported as the Cardiac and Vascular Group, includes the Cardiac Rhythm & Heart Failure, Structural Heart & Aortic and Coronary & Peripheral Vascular divisions. The Medical Surgical Portfolio, formerly reported as the Minimally Invasive Therapies Group, includes the Surgical Innovations and the Respiratory, Gastrointestinal & Renal divisions. Neuroscience consists of Cranial & Spinal Technologies, Specialty The Neuroscience Portfolio, formerly reported as the Restorative Therapies Group, includes the Cranial & Spinal Technologies, Specialty Therapies, and Neuromodulation divisions. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Abbott Laboratories (ABT) | United States | $186.584B | 24.49 |
Stryker (SYK) | United States | $127.690B | 31.66 |
Boston Scientific (BSX) | United States | $107.347B | 34.19 |
EssilorLuxottica (ESLOY) | France | $98.566B | 0.00 |
Lonza Group Ag (LZAGY) | Switzerland | $43.036B | 0.00 |
Haleon (HLN) | United Kingdom | $38.584B | 30.18 |
ResMed (RMD) | United States | $32.074B | 30.08 |
Terumo (TRUMY) | Japan | $24.746B | 34.95 |
Zimmer Biomet Holdings (ZBH) | United States | $24.522B | 15.79 |
Baxter (BAX) | United States | $20.379B | 14.86 |
Koninklijke Philips (PHG) | Netherlands | $19.567B | 15.61 |
Insulet (PODD) | United States | $11.637B | 61.10 |
Smith & Nephew SNATS (SNN) | United Kingdom | $10.689B | 0.00 |
Demant (WILYY) | Denmark | $9.943B | 0.00 |
Bio-Rad Laboratories (BIO) | United States | $7.869B | 23.44 |
BellRing Brands (BRBR) | United States | $7.379B | 39.68 |
Haemonetics (HAE) | United States | $4.621B | 23.63 |
Lantheus Holdings (LNTH) | United States | $4.494B | 11.60 |
Perrigo (PRGO) | Ireland | $4.328B | 12.38 |
GN Store Nord (GNNDY) | Denmark | $4.065B | 26.32 |
Envista Holdings (NVST) | United States | $3.504B | 13.33 |
Prestige Consumer Healthcare (PBH) | United States | $3.499B | 16.54 |
QuidelOrtho (QDEL) | United States | $2.651B | 9.62 |
Neogen (NEOG) | United States | $2.630B | 25.29 |
Green Thumb Industries (GTBIF) | United States | $2.571B | 81.47 |
ICU Medical (ICUI) | United States | $2.311B | 17.24 |
TG Therapeutics (TGTX) | United States | $2.082B | 673.50 |
Maravai LifeSciences Holdings (MRVI) | United States | $1.936B | 0.00 |
Owens & Minor (OMI) | United States | $1.922B | 18.45 |
Agios Pharmaceuticals (AGIO) | United States | $1.770B | 0.00 |
Verano Holdings (VRNOF) | United States | $1.697B | 0.00 |
LeMaitre Vascular (LMAT) | United States | $1.469B | 48.49 |
InMode (INMD) | Israel | $1.439B | 7.45 |
National Vision Holdings (EYE) | United States | $1.400B | 43.61 |
AdaptHealth (AHCO) | United States | $1.324B | 9.96 |
Warby Parker (WRBY) | United States | $1.271B | 0.00 |
AtriCure (ATRC) | United States | $1.121B | 0.00 |
MacroGenics (MGNX) | United States | $0.911B | 0.00 |
Canopy Growth (CGC) | Canada | $0.893B | 0.00 |
BioLife Solutions (BLFS) | United States | $0.794B | 0.00 |
Cresco Labs (CRLBF) | United States | $0.709B | 0.00 |
VAREX IMAGING (VREX) | United States | $0.682B | 14.73 |
Evolus (EOLS) | United States | $0.662B | 0.00 |
Jin Medical (ZJYL) | China | $0.626B | 0.00 |
Quanterix (QTRX) | United States | $0.595B | 0.00 |
Valneva SE (VALN) | France | $0.532B | 0.00 |
Phibro Animal Health (PAHC) | United States | $0.516B | 11.17 |
PetIQ (PETQ) | United States | $0.486B | 18.16 |
TerrAscend (TSNDF) | Canada | $0.486B | 0.00 |
ZimVie (ZIMV) | United States | $0.431B | 26.37 |
Biote (BTMD) | United States | $0.411B | 3.91 |
OraSure Technologies (OSUR) | United States | $0.407B | 6.73 |
Surmodics (SRDX) | United States | $0.373B | 40.26 |
Aurora Cannabis (ACB) | Canada | $0.365B | 0.00 |
Zynex (ZYXI) | United States | $0.361B | 41.52 |
Viemed Healthcare (VMD) | United States | $0.322B | 31.96 |
Cerus (CERS) | United States | $0.310B | 0.00 |
Sanara MedTech (SMTI) | United States | $0.279B | 0.00 |
TriSalus Life Sciences (TLSI) | United States | $0.250B | 0.00 |
Utah Medical Products (UTMD) | United States | $0.237B | 14.65 |
Organigram Holdings (OGI) | Canada | $0.192B | 0.00 |
Veru (VERU) | United States | $0.186B | 0.00 |
Ayr Wellness (AYRWF) | United States | $0.183B | 0.00 |
Omeros (OMER) | United States | $0.183B | 0.00 |
Capricor Therapeutics (CAPR) | United States | $0.170B | 0.00 |
High Tide (HITI) | Canada | $0.161B | 0.00 |
Quipt Home Medical (QIPT) | United States | $0.156B | 0.00 |
Eagleford Energy (GRUSF) | United States | $0.144B | 72.36 |
FitLife Brands (FTLF) | United States | $0.132B | 21.28 |
Jushi Holdings (JUSHF) | United States | $0.131B | 0.00 |
InterCure (INCR) | Israel | $0.121B | 20.46 |
Fonar (FONR) | United States | $0.103B | 8.84 |
MariMed (MRMD) | United States | $0.100B | 0.00 |
Oramed Pharmaceuticals (ORMP) | United States | $0.100B | 0.00 |
Cellectar Biosciences (CLRB) | United States | $0.098B | 0.00 |
Allurion Technologies (ALUR) | United States | $0.092B | 0.00 |
Safety Shot (SHOT) | United States | $0.082B | 0.00 |
Chimerix (CMRX) | United States | $0.080B | 0.00 |
Brainsway (BWAY) | Israel | $0.079B | 0.00 |
Zevia PBC (ZVIA) | United States | $0.058B | 0.00 |
Eagle Pharmaceuticals (EGRX) | United States | $0.054B | 3.53 |
Apyx Medical (APYX) | United States | $0.050B | 0.00 |
Cytosorbents (CTSO) | United States | $0.044B | 0.00 |
Rockwell Medical (RMTI) | United States | $0.043B | 0.00 |
ImmuCell (ICCC) | United States | $0.040B | 0.00 |
United-Guardian (UG) | United States | $0.038B | 14.77 |
Bright Green (BGXX) | United States | $0.038B | 0.00 |
Modular Medical (MODD) | United States | $0.035B | 0.00 |
Exagen (XGN) | United States | $0.024B | 0.00 |
Nephros (NEPH) | United States | $0.023B | 0.00 |
FSD PHARMA (HUGE) | Canada | $0.019B | 0.00 |
Flora Growth (FLGC) | United States | $0.017B | 0.00 |
Meihua Medical Technologies (MHUA) | China | $0.017B | 0.00 |
Agape ATP (ATPC) | $0.017B | 0.00 | |
Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
GlucoTrack (GCTK) | United States | $0.012B | 0.00 |
GUARDION HEALTH (GHSI) | United States | $0.010B | 71.82 |
NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
IM Cannabis (IMCC) | Canada | $0.007B | 0.00 |
Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
Sharps Technology (STSS) | United States | $0.004B | 0.00 |
Senestech (SNES) | United States | $0.004B | 0.00 |
Innovative Eyewear (LUCY) | United States | $0.003B | 0.00 |
Lucy Scientific Discovery (LSDI) | Canada | $0.001B | 0.00 |
Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
Smart For Life (SMFL) | United States | $0.000B | 0.00 |
Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
SNDL (SNDL) | Canada | $0.000B | 0.00 |